TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Conversion Labs, Inc. (OTC: CVLB) Investor Investigation Over Potential Wrongdoing Announced

  • Investors who purchased shares of Conversion Labs, Inc. (OTC: CVLB) have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Conversion Labs, Inc.
Security
OTC: CVLB

Summary

An investigation on behalf of investors in shares of Conversion Labs, Inc. (OTC: CVLB) was announced over potential breaches of fiduciary duties by certain officers and directors at Conversion Labs, Inc.

The investigation by a law firm concerns whether certain Conversion Labs, Inc. (OTC: CVLB officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

New York based Conversion Labs, Inc. operates as an online direct-to-consumer marketing and telemedicine company worldwide. Conversion Labs, Inc. reported that its annual Total Revenue rose from $8.32 million in 2018 to $12.46 million in 2019, and that its Net Loss increased from $1.24 million in 2018 to $3.13 million in 2019.

Shares of Conversion Labs, Inc. (OTC: CVLB) increased from $0.10 per share in March 2020, to as high as $1.12 per share on July 21, 2020.

Start Monitoring Your Investments